KALV
KalVista Pharmaceuticals Inc

3,115
Mkt Cap
$692.99M
Volume
1.13M
52W High
$17.28
52W Low
$7.30
PE Ratio
-3.43
KALV Fundamentals
Price
$13.02
Prev Close
$13.71
Open
$13.83
50D MA
$12.09
Beta
0.95
Avg. Volume
1.19M
EPS (Annual)
-$3.69
P/B
16.92
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Benjamin Palleiko Sells 3,328 Shares of KalVista Pharmaceuticals (NASDAQ:KALV) Stock
KalVista Pharmaceuticals, Inc. (NASDAQ:KALV - Get Free Report) CEO Benjamin Palleiko sold 3,328 shares of KalVista Pharmaceuticals stock in a transaction on Wednesday, November 12th. The stock was...
MarketBeat·5d ago
News Placeholder
More News
News Placeholder
Analysts Issue Forecasts for KALV FY2025 Earnings
KalVista Pharmaceuticals, Inc. (NASDAQ:KALV - Free Report) - HC Wainwright issued their FY2025 earnings estimates for shares of KalVista Pharmaceuticals in a report issued on Thursday, November 13th...
MarketBeat·5d ago
News Placeholder
FY2025 Earnings Forecast for KALV Issued By Leerink Partnrs
KalVista Pharmaceuticals, Inc. (NASDAQ:KALV - Free Report) - Research analysts at Leerink Partnrs upped their FY2025 earnings per share (EPS) estimates for shares of KalVista Pharmaceuticals in a...
MarketBeat·5d ago
News Placeholder
KalVista Pharmaceuticals (NASDAQ:KALV) CEO Benjamin Palleiko Sells 3,328 Shares
KalVista Pharmaceuticals, Inc. (NASDAQ:KALV - Get Free Report) CEO Benjamin Palleiko sold 3,328 shares of KalVista Pharmaceuticals stock in a transaction on Wednesday, November 12th. The stock was...
MarketBeat·6d ago
News Placeholder
KalVista Pharmaceuticals (NASDAQ:KALV) Trading Up 7% - Here's What Happened
KalVista Pharmaceuticals (NASDAQ:KALV) Trading 7% Higher - Here's Why...
MarketBeat·7d ago
News Placeholder
Nan Fung Trinity HK Ltd. Acquires Shares of 154,522 KalVista Pharmaceuticals, Inc. $KALV
Nan Fung Trinity HK Ltd. bought a new position in shares of KalVista Pharmaceuticals, Inc. (NASDAQ:KALV - Free Report) in the second quarter, according to the company in its most recent Form 13F...
MarketBeat·7d ago
News Placeholder
KalVista Pharmaceuticals (NASDAQ:KALV) Shares Gap Up on Earnings Beat
KalVista Pharmaceuticals (NASDAQ:KALV) Shares Gap Up After Better-Than-Expected Earnings...
MarketBeat·8d ago
News Placeholder
Traders Purchase Large Volume of KalVista Pharmaceuticals Put Options (NASDAQ:KALV)
KalVista Pharmaceuticals, Inc. (NASDAQ:KALV - Get Free Report) was the target of unusually large options trading activity on Tuesday. Traders acquired 5,001 put options on the company. This is an...
MarketBeat·8d ago
News Placeholder
Citizens Jmp Issues Pessimistic Forecast for KalVista Pharmaceuticals (NASDAQ:KALV) Stock Price
Citizens Jmp reduced their price objective on KalVista Pharmaceuticals from $29.00 to $28.00 and set a "market outperform" rating for the company in a report on Tuesday...
MarketBeat·8d ago
News Placeholder
KalVista Pharmaceuticals (NASDAQ:KALV) Releases Quarterly Earnings Results, Beats Expectations By $0.04 EPS
KalVista Pharmaceuticals (NASDAQ:KALV - Get Free Report) announced its quarterly earnings results on Monday. The specialty pharmaceutical company reported ($0.92) earnings per share (EPS) for the...
MarketBeat·9d ago

Latest KALV News

View

Advertisement|Remove ads.

Advertisement|Remove ads.